Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Clinical and Molecular Hepatology|January 30, 2023
Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific regionDo Young Kim, Bao Nguyen Toan, Chee-Kiat Tan, et al.
Journal of Hepatology|March 28, 2025
Health-related quality of life in participants with advanced biliary tract cancer from the randomized phase III KEYNOTE-966 studyChanghoon Yoo, Makoto Ueno, Heinz-Josef Klümpen, et al.
Alimentary Pharmacology & Therapeutics|February 23, 2023
Trends in risk factor control and treatment among patients with non-alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory-wide studyXinrong Zhang, Terry Cheuk-Fung Yip, Yee-Kit Tse, et al.
Liver Cancer|May 29, 2015
Hong Kong consensus recommendations on the management of hepatocellular carcinomaRonnie Tung-Ping Poon, Tom Tan-To Cheung, Philip Chong-Hei Kwok, et al.
Science Translational Medicine|April 8, 2021
A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinomaWeiqin Yang, Yu Feng, Jingying Zhou, et al.
Journal of Gastroenterology and Hepatology|May 23, 2023
Baveno VII criteria identify varices needing treatment in patients with hepatocellular carcinoma of different Barcelona Clinic Liver Cancer stagesClaudia Wing-Kwan Wu, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, et al.
Nature Communications|November 11, 2025
Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinomaMartina Mang Leng Lei, Carmen Oi Ning Leung, Rainbow Wing Hei Leung, et al.
JHEP Reports : Innovation in Hepatology|June 17, 2024
PPP1R15A-expressing monocytic MDSCs promote immunosuppressive liver microenvironment in fibrosis-associated hepatocellular carcinomaXiaoyu Liu, Man Liu, Haoran Wu, et al.
Pageof 7